Related references
Note: Only part of the references are listed.LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
Christos V. Rizos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
Marta Futema et al.
ATHEROSCLEROSIS (2021)
Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia
Elisenda Climent et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort
Christopher Blaum et al.
CLINICAL THERAPEUTICS (2021)
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M. Ballantyne et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Clinical review on triglycerides
Ulrich Laufs et al.
EUROPEAN HEART JOURNAL (2020)
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
Raul D. Santos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia
Maria Donata Di Taranto et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease A Systematic Review and Meta-Analysis
Pengwei Hu et al.
CIRCULATION (2020)
PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study
Stephen Daniels et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
Worldwide Prevalence of Familial Hypercholesterolemia Meta-Analyses of 11 Million Subjects
Sabina O. Beheshti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cardiovascular Health Trajectories From Childhood Through Middle Age and Their Association With Subclinical Atherosclerosis
Norrina B. Allen et al.
JAMA CARDIOLOGY (2020)
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Michael J. Domanski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
Raul D. Santos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Management of hypertriglyceridemia
Vinaya Simha
BMJ-BRITISH MEDICAL JOURNAL (2020)
Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study
Atsushi Nohara et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Cardiovascular Risk Reduction in High-Risk Pediatric Patients A Scientific Statement From the American Heart Association
Sarah D. de Ferranti et al.
CIRCULATION (2019)
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Tawfeg Ben-Omran et al.
ADVANCES IN THERAPY (2019)
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Ulrich Laufs et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Ann C. Skulas-Ray et al.
CIRCULATION (2019)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
Leopoldo Perez de Isla et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia
Michael J. Koren et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
I. K. Luirink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Severe hypertriglyceridemia is primarily polygenic
Jacqueline S. Dron et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
Christie M. Ballantyne et al.
ATHEROSCLEROSIS (2018)
Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use
Fariba Ahmadizar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
The Physical Activity Guidelines for Americans
Katrina L. Piercy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians
Sarah D. de Ferranti et al.
JOURNAL OF PEDIATRICS (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
Mark J. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin Fitzgerald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Approach to Hypertriglyceridemia in the Pediatric Population
Badhma Valaiyapathi et al.
PEDIATRICS IN REVIEW (2017)
Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry
Mafalda Bourbon et al.
ATHEROSCLEROSIS (2017)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry
Emil M. deGoma et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia
Michael M. Mendelson et al.
JOURNAL OF PEDIATRICS (2016)
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
Stephen L. Pinkosky et al.
NATURE COMMUNICATIONS (2016)
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry
Emil M. deGoma et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
Dean J. Kereiakes et al.
AMERICAN HEART JOURNAL (2015)
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Albert Wiegman et al.
EUROPEAN HEART JOURNAL (2015)
Temporal trends in lipid screening and therapy among youth from 2002 to 2012
Justin P. Zachariah et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia
D. Meeike Kusters et al.
JOURNAL OF PEDIATRICS (2015)
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk
Marjet J. A. M. Braamskamp et al.
JOURNAL OF PEDIATRICS (2015)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency
B. K. Burton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
Marjet J. A. M. Braamskamp et al.
PEDIATRIC DRUGS (2015)
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome
Barbara Sjouke et al.
EUROPEAN HEART JOURNAL (2015)
Using High-Dose Omega-3 Fatty Acid Supplements to Lower Triglyceride Levels in 10-to 19-Year-Olds
Sarah D. de Ferranti et al.
CLINICAL PEDIATRICS (2014)
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia The LAPLACE-2 Randomized Clinical Trial
Jennifer G. Robinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia
D. Meeike Kusters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
A Double-Blind Randomized Trial of Fish Oil to Lower Triglycerides and Improve Cardiometabolic Risk in Adolescents
Samuel S. Gidding et al.
JOURNAL OF PEDIATRICS (2014)
Implementation of Lipid Screening Guidelines in Children by Primary Pediatric Providers
Damon B. Dixon et al.
JOURNAL OF PEDIATRICS (2014)
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
Erik Stroes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Anti-PCSK9 Monotherapy for Hypercholesterolemia The MENDEL-2 Randomized, Controlled Phase III Clinical Trial of Evolocumab
Michael J. Koren et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
The Fetal Safety of Statins: A Systematic Review and Meta-Analysis
Judith Zarek et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2014)
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Marina Cuchel et al.
LANCET (2013)
Secondary Causes of Dyslipidemia
Deepthi Vodnala et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
Raul D. Santos et al.
ATHEROSCLEROSIS (2012)
Hypertriglyceridemia secondary to obesity and diabetes
Savitha Subramanian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Ideal Cardiovascular Health in Childhood and Cardiometabolic Outcomes in Adulthood The Cardiovascular Risk in Young Finns Study
Tomi T. Laitinen et al.
CIRCULATION (2012)
Low-Density Lipoprotein Cholesterol-Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia The Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) Randomized Trial
Frederick Raal et al.
CIRCULATION (2012)
Lipid-Modifying Therapies and Risk of Pancreatitis A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients The GAUSS Randomized Trial
David Sullivan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other Lipids: A review
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR
Yan Wang et al.
JOURNAL OF LIPID RESEARCH (2012)
Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy
James M. McKenney et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
Michael J. Koren et al.
LANCET (2012)
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
Robert P. Giugliano et al.
LANCET (2012)
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
Evan A. Stein et al.
LANCET (2012)
Ezetimibe as Monotherapy in the Treatment of Hypercholesterolemia in Children and Adolescents
D. Yeste et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2011)
Influence of Age on Associations Between Childhood Risk Factors and Carotid Intima-Media Thickness in Adulthood The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium
Markus Juonala et al.
CIRCULATION (2010)
Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia
Evan A. Stein et al.
JOURNAL OF PEDIATRICS (2010)
Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
Hans J. Avis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia
Anouk van der Graaf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
Frederick F. Samaha et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis
C. Arambepola et al.
ATHEROSCLEROSIS (2007)
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis
David S. Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Impact of repeated dietary Counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins -: The STRIP study
Harri Niinikoski et al.
CIRCULATION (2007)
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia
H. J. Avis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia
Anouk van der Graaf et al.
ACTA PAEDIATRICA (2006)
Familial combined hyperlipidemia: upstream transcription factor 1 and beyond
JC Lee et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study)
MM Engler et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia
G Salen et al.
CIRCULATION (2004)
Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized controlled trial
A Wiegman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial
BW McCrindle et al.
JOURNAL OF PEDIATRICS (2003)
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
DJ Rader et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factors in overweight adolescents
SB Sondike et al.
JOURNAL OF PEDIATRICS (2003)
Mechanism of action of statins and fibrates
P Duriez
THERAPIE (2003)
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
S de Jongh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized, double-blind, placebo-controlled trial with simvastatin
S de Jongh et al.
CIRCULATION (2002)
Share Paper
